Michigan Medicine 27th Annual Liver Disease Wrap-Up 2024

Michigan Medicine 27th Annual Liver Disease Wrap-Up 2024

The Michigan Medicine 27th Annual Liver Disease Wrap-Up 2024 is a comprehensive hepatology update designed to provide healthcare professionals with the latest evidence-based advances in the diagnosis, treatment, and management of liver diseases. Presented by leading hepatology experts from the University of Michigan Medical School, this annual program reviews current clinical guidelines, emerging therapies, and practical approaches to managing both common and complex liver disorders.

Using case-based presentations, clinical research updates, expert discussions, and interactive Q&A sessions, the course equips clinicians with practical knowledge that can be immediately incorporated into patient care. Participants will review modern strategies for evaluating liver disease, selecting appropriate diagnostic tests and imaging studies, implementing current treatment recommendations, and identifying patients who require referral for specialized hepatology care or liver transplantation.

Included Content

• Video Lectures
• Expert Panel Discussions
• Interactive Q&A Sessions
• Case-Based Clinical Reviews
• Evidence-Based Hepatology Updates

Educational Focus

This program provides practical updates in:

• Hepatology
• Chronic Liver Disease
• Metabolic Liver Disease
• Liver Transplantation
• Hepatocellular Carcinoma (HCC)
• Alcohol-Associated Liver Disease
• Autoimmune Liver Disease
• Cholestatic Liver Disease
• Genetic Liver Disorders
• Evidence-Based Liver Care

Key Topics Covered

Metabolic Associated Steatotic Liver Disease (MASLD)

• Diagnosis and staging of MASLD
• Current treatment strategies
• Lifestyle and metabolic interventions
• Disease progression and monitoring

Alcohol-Associated Liver Disease

• Alcohol-associated hepatitis
• Cirrhosis management
• Alcohol use disorder treatment
• Behavioral and pharmacologic therapies

Cholestatic, Autoimmune & Genetic Liver Disease

• Primary biliary diseases
• Autoimmune hepatitis
• Genetic liver disorders
• Contemporary diagnostic approaches

Hepatocellular Carcinoma (HCC)

• Early diagnosis
• Updated treatment strategies
• Immunotherapy in liver cancer
• Multidisciplinary management

Advanced Liver Disease & Liver Transplantation

• Decompensated cirrhosis
• Liver transplant evaluation
• Organ preservation advances
• Post-transplant considerations

Learning Objectives

After completing this activity, participants will be able to:

• Apply the latest evidence-based recommendations for diagnosing and managing MASLD.
• Recognize new developments in cholestatic, autoimmune, and inherited liver diseases.
• Implement current treatment strategies for alcohol-associated liver disease and cirrhosis.
• Evaluate modern therapeutic options, including immunotherapy for hepatocellular carcinoma.
• Understand recent advances in liver transplantation and organ preservation.
• Select appropriate laboratory tests, imaging studies, and referral strategies for patients with liver disease.

Educational Benefits

Participants will gain practical, evidence-based knowledge on the diagnosis and management of metabolic liver disease, alcohol-associated liver disease, autoimmune liver disorders, hepatocellular carcinoma, and advanced liver disease. The program combines current clinical guidelines, expert recommendations, and real-world case discussions to improve decision-making, optimize patient outcomes, and enhance confidence in the management of liver disorders.